30th Jun 2005 16:00
AstraZeneca PLC30 June 2005 Dealing by DirectorsCompanies Act 1985 Sections 324/329 We hereby inform you that on 29 June 2005 the following Directors of AstraZenecaPLC were each granted an award under the terms of the AstraZeneca PerformanceShare Plan over the Company's USD0.25 Ordinary Shares. Target number of Award price Total interest in Percentage ofName of Director shares awarded per share Normal vesting shares after this shares in issue date award Sir Tom McKillop 104,417 2241p 29 June 2008 197,032 0.012% J R Symonds 47,723 2241p 29 June 2008 59,250 0.004% J S Patterson 41,945 2241p 29 June 2008 42,448 0.003% The AstraZeneca Performance Share Plan was approved by shareholders at theCompany's AGM on 28 April 2005. Awards made under the Plan may not generallyvest before the third anniversary of the relevant date of grant nor unless thespecified performance target(s) have been met at the end of the three yearperiod which, for this award, is 1 January 2005 to 31 December 2007. The performance target that applies to this award is the Company's TotalShareholder Return ("TSR") compared to the TSR of a selected peer group of 12other pharmaceutical companies. The actual number of shares to which aparticipant may become unconditionally entitled will depend on the extent towhich the performance target(s) have been met. A summary of the Plan, includinga more detailed explanation of the performance target(s), can be found in theAstraZeneca Notice of AGM 2005 which is available on the Company's websitewww.astrazeneca.com. David R. Brennan, a Director of the Company, who is not included in this award,was granted an award of shares under the terms of the AstraZeneca US ExecutivePerformance Share Plan in March 2005 as previously announced. G H R MuskerCompany Secretary30 June 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca